Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
September-2020 Volume 46 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2020 Volume 46 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model

  • Authors:
    • Zexi Xu
    • Yadong Li
    • Dahong Wang
    • Daoqiu Wu
    • Jinyun Wang
    • Lian Chen
    • Yinqian Deng
    • Jing Zhang
    • Zhixiong Wu
    • Xin Wan
    • Qianfan Liu
    • Hai Huang
    • Pingsheng Hu
    • Jiawei Zeng
    • Ding'an Zhou
  • View Affiliations / Copyright

    Affiliations: Clinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China, Clinical College, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China, School of Clinical Laboratory Sciences, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China, School of Biology and Engineering, Guizhou Medical University, Guiyang, Guizhou 550025, P.R. China, Department of Clinical Laboratory, Mianyang Central Hospital, Mianyang, Sichuan 621000, P.R. China
    Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1118-1134
    |
    Published online on: June 19, 2020
       https://doi.org/10.3892/ijmm.2020.4652
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The SAM and SH3 domain‑containing 1 (SASH1) genes have been identified as the causal genes of dyschromatosis universalis hereditaria (DUH); these genes cause the pathological phenotypes of DUH, and SASH1 variants have been shown to regulate the abnormal pigmentation phenotype in human skin in various genodermatoses. However, investigations into the mutated SASH1 gene have been limited to in vitro studies. In the present study, to recapitulate the molecular pathological phenotypes of individuals with DUH induced by SASH1 mutations, a heterozygous BALB/c mouse model, in which the human SASH1 c.1654 T>G (p. Tyr 551Asp, Y551D) mutation was knocked in was first generated. The in vivo functional experiments on Y551D SASH1 indicated that the increased expression of microphthalmia‑associated transcription factor (Mitf) was uniformly induced in the tails of heterozygous BALB/c mice, and an increased quantity of Mitf‑positive epithelial cells was also detected. An increased expression of Mitf‑ and Mitf‑positive cells was also demonstrated in the epithelial tissues of Y551D‑SASH1 affected individuals. In the present study, Mitf expression was also found to be increased by Y551D SASH1 in vitro. Taken together, these findings indicate that the upregulation of Mitf is the bona fide effector of the Y551D SASH1‑mediated melanogenesis signaling pathway in vivo. SASH1 may function as a scaffold molecule for the assembly of a SASH1‑Mitf molecular complex to regulate Mitf expression in the cell nucleus and thus to promote the hyperpigmented phenotype in the pathogenesis of DUH and other genodermatoses related to pigment abnormalities.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Xing QH, Wang MT, Chen XD, Feng GY, Ji HY, Yang JD, Gao JJ, Qin W, Qian XQ, Wu SN and He L: A gene locus responsible for dyschromatosis symmetrica hereditaria (DSH) maps to chromosome 6q24.2-q25.2. Am J Hum Genet. 73:377–382. 2003. View Article : Google Scholar : PubMed/NCBI

2 

Zhou D, Wei Z, Deng S, Wang T, Zai M, Wang H, Guo L, Zhang J, Zhong H, He L and Xing Q: SASH1 regulates melanocyte transepithelial migration through a novel Gαs-SASH1-IQGAP1-E-cadherin dependent pathway. Cell Signal. 25:1526–1538. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Zhou D, Wei Z, Kuang Z, Luo H, Ma J, Zeng X, Wang K, Liu B, Gong F, Wang J, et al: A novel P53/POMC/Gαs/SASH1 auto-regulatory feedback loop activates mutated SASH1 to cause pathologic hyperpigmentation. J Cell Mol Med. 21:802–815. 2017. View Article : Google Scholar

4 

Zhou D, Kuang Z, Zeng X, Wang K, Ma J, Luo H, Chen M, Li Y, Zeng J, Li S, et al: p53 regulates ERK1/2/CREB cascade via a novel SASH1/MAP2K2 crosstalk to induce hyperpigmentation. J Cell Mol Med. 21:2465–2480. 2017. View Article : Google Scholar : PubMed/NCBI

5 

Zhong WL, Wang HJ, Lin ZM and Yang Y: Novel mutations in SASH1 associated with dyschromatosis universalis hereditaria. Indian J Dermatol Venereol Leprol. 85:4402019. View Article : Google Scholar

6 

Shellman YG, Lambert KA, Brauweiler A, Fain P, Spritz RA, Martini M, Janssen KP, Box NF, Terzian T, Rewers M, et al: SASH1 is involved in an autosomal dominant lentiginous phenotype. J Invest Dermatol. 135:3192–3194. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Wang J, Zhang J, Li X, Wang Z, Lei D, Wang G, Li J, Zhang S, Li Z and Li M: A novel de novo mutation of the SASH1 gene in a chinese family with multiple lentigines. Acta Derm Venereol. 97:530–531. 2017. View Article : Google Scholar

8 

Zhang J, Cheng R, Liang J, Ni C, Li M and Yao Z: Lentiginous phenotypes caused by diverse pathogenic genes (SASH1 and PTPN11): Clinical and molecular discrimination. Clin Genet. 90:372–377. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Courcet JB, Elalaoui SC, Duplomb L, Tajir M, Rivière JB, Thevenon J, Gigot N, Marle N, Aral B, Duffourd Y, et al: Autosomal-recessive SASH1 variants associated with a new genodermatosis with pigmentation defects, palmoplantar keratoderma and skin carcinoma. Eur J Hum Genet. 23:957–962. 2015. View Article : Google Scholar :

10 

Martini M, Gnann A, Scheikl D, Holzmann B and Janssen KP: The candidate tumor suppressor SASH1 interacts with the actin cytoskeleton and stimulates cell-matrix adhesion. Int J Biochem Cell Biol. 43:1630–1640. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Kundumani-Sridharan V, Subramani J, Raghavan S, Maiti GP, Owens C, Walker T, Wasnick J, Idell S and Das KC: Short-duration hyperoxia causes genotoxicity in mouse lungs: Protection by volatile anesthetic isoflurane. Am J Physiol Lung Cell Mol Physiol. 316:L903–L917. 2019. View Article : Google Scholar : PubMed/NCBI

12 

Jiang Y, Xie X, Zhang Y, Luo X, Wang X, Fan F, Zheng D, Wang Z and Chen Y: Regulation of G-protein signaling by RKTG via sequestration of the G betagamma subunit to the Golgi apparatus. Mol Cell Biol. 30:78–90. 2010. View Article : Google Scholar

13 

Englaro W, Rezzonico R, Durand-Clément M, Lallemand D, Ortonne JP and Ballotti R: Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melano-genesis in B-16 melanoma cells. J Biol Chem. 270:24315–24320. 1995. View Article : Google Scholar : PubMed/NCBI

14 

Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP and Ballotti R: Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol. 142:827–835. 1998. View Article : Google Scholar : PubMed/NCBI

15 

Hemesath TJ, Price ER, Takemoto C, Badalian T and Fisher DE: MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature. 391:298–301. 1998. View Article : Google Scholar : PubMed/NCBI

16 

Primot A, Mogha A, Corre S, Roberts K, Debbache J, Adamski H, Dreno B, Khammari A, Lesimple T, Mereau A, et al: ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma. Pigment Cell Melanoma Res. 23:93–102. 2010. View Article : Google Scholar

17 

Fock V, Gudmundsson SR, Gunnlaugsson HO, Stefansson JA, Ionasz V, Schepsky A, Viarigi J, Reynisson IE, Pogenberg V, Wilmanns M, et al: Subcellular localization and stability of MITF are modulated by the bHLH-Zip domain. Pigment Cell Melanoma Res. 32:41–54. 2019. View Article : Google Scholar

18 

Bouché V, Espinosa AP, Leone L, Sardiello M, Ballabio A and Botas J: Drosophila Mitf regulates the V-ATPase and the lysosomal-autophagic pathway. Autophagy. 12:484–498. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Ichigawa T and Hiraga Y: A previously undescribed anomaly of pigmentation dyschromatosis universalis hereditaria. Jpn J Dermatol Urol. 34:360–364. 1933.In Japanese.

20 

Zhang C, Li D, Zhang J, Chen X, Huang M, Archacki S, Tian Y, Ren W, Mei A, Zhang Q, et al: Mutations in ABCB6 cause dyschromatosis universalis hereditaria. J Invest Dermatol. 133:2221–2228. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Xie J, Zhang W, Zhang J, Lv QY and Luan YF: Downregulation of SASH1 correlates with poor prognosis in cervical cancer. Eur Rev Med Pharmacol Sci. 21:3781–3786. 2017.PubMed/NCBI

22 

Gong X, Wu J, Wu J, Liu J, Gu H and Shen H: Correlation of SASH1 expression and ultrasonographic features in breast cancer. Onco Targets Ther. 10:271–276. 2017. View Article : Google Scholar : PubMed/NCBI

23 

He P, Zhang HX, Sun CY, Chen CY and Jiang HQ: Overexpression of SASH1 inhibits the proliferation, invasion, and EMT in hepatocarcinoma cells. Oncol Res. 24:25–32. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Dubois F, Vandermoere F, Gernez A, Murphy J, Toth R, Chen S, Geraghty KM, Morrice NA and MacKintosh C: Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling. Mol Cell Proteomics. 8:2487–2499. 2009. View Article : Google Scholar : PubMed/NCBI

25 

Coulombe P, Paliouras GN, Clayton A, Hussainkhel A, Fuller M, Jovanovic V, Dauphinee S, Umlandt P, Xiang P, Kyle AH, et al: Endothelial Sash1 is required for lung maturation through nitric oxide signaling. Cell Rep. 27:1769–1780.e4. 2019. View Article : Google Scholar : PubMed/NCBI

26 

Price ER, Ding HF, Badalian T, Bhattacharya S, Takemoto C, Yao TP, Hemesath TJ and Fisher DE: Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microph-thalmia. J Biol Chem. 273:17983–17986. 1998. View Article : Google Scholar : PubMed/NCBI

27 

Gonzalez GA and Montminy MR: Cyclic AMP stimulates soma-tostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 59:675–680. 1989. View Article : Google Scholar : PubMed/NCBI

28 

Jin ML, Park SY, Kim YH, Park G, Son HJ and Lee SJ: Suppression of α-MSH and IBMX-induced melanogenesis by cordycepin via inhibition of CREB and MITF, and activation of PI3K/Akt and ERK-dependent mechanisms. Int J Mol Med. 29:119–124. 2012.

29 

Kim HE, Ishihara A and Lee SG: The effects of Caffeoylserotonin on inhibition of melanogenesis through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16 murine melanoma cells. BMB Rep. 45:724–729. 2012. View Article : Google Scholar : PubMed/NCBI

30 

Saha B, Singh SK, Sarkar C, Bera R, Ratha J, Tobin DJ and Bhadra R: Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. Pigment Cell Res. 19:595–605. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Yun CY, You ST, Kim JH, Chung JH, Han SB, Shin EY and Kim EG: p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways. J Invest Dermatol. 135:1385–1394. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Dauphinee SM, Clayton A, Hussainkhel A, Yang C, Park YJ, Fuller ME, Blonder J, Veenstra TD and Karsan A: SASH1 is a scaffold molecule in endothelial TLR4 signaling. J Immunol. 191:892–901. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu Z, Li Y, Wang D, Wu D, Wang J, Chen L, Deng Y, Zhang J, Wu Z, Wan X, Wan X, et al: Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model. Int J Mol Med 46: 1118-1134, 2020.
APA
Xu, Z., Li, Y., Wang, D., Wu, D., Wang, J., Chen, L. ... Zhou, D. (2020). Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model. International Journal of Molecular Medicine, 46, 1118-1134. https://doi.org/10.3892/ijmm.2020.4652
MLA
Xu, Z., Li, Y., Wang, D., Wu, D., Wang, J., Chen, L., Deng, Y., Zhang, J., Wu, Z., Wan, X., Liu, Q., Huang, H., Hu, P., Zeng, J., Zhou, D."Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model". International Journal of Molecular Medicine 46.3 (2020): 1118-1134.
Chicago
Xu, Z., Li, Y., Wang, D., Wu, D., Wang, J., Chen, L., Deng, Y., Zhang, J., Wu, Z., Wan, X., Liu, Q., Huang, H., Hu, P., Zeng, J., Zhou, D."Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model". International Journal of Molecular Medicine 46, no. 3 (2020): 1118-1134. https://doi.org/10.3892/ijmm.2020.4652
Copy and paste a formatted citation
x
Spandidos Publications style
Xu Z, Li Y, Wang D, Wu D, Wang J, Chen L, Deng Y, Zhang J, Wu Z, Wan X, Wan X, et al: Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model. Int J Mol Med 46: 1118-1134, 2020.
APA
Xu, Z., Li, Y., Wang, D., Wu, D., Wang, J., Chen, L. ... Zhou, D. (2020). Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model. International Journal of Molecular Medicine, 46, 1118-1134. https://doi.org/10.3892/ijmm.2020.4652
MLA
Xu, Z., Li, Y., Wang, D., Wu, D., Wang, J., Chen, L., Deng, Y., Zhang, J., Wu, Z., Wan, X., Liu, Q., Huang, H., Hu, P., Zeng, J., Zhou, D."Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model". International Journal of Molecular Medicine 46.3 (2020): 1118-1134.
Chicago
Xu, Z., Li, Y., Wang, D., Wu, D., Wang, J., Chen, L., Deng, Y., Zhang, J., Wu, Z., Wan, X., Liu, Q., Huang, H., Hu, P., Zeng, J., Zhou, D."Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model". International Journal of Molecular Medicine 46, no. 3 (2020): 1118-1134. https://doi.org/10.3892/ijmm.2020.4652
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team